Related Experiment Video
Updated: Jul 26, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
A Rare Case of Moyamoya Disease in a Patient With Sickle Cell Disease
Ayman Mohamed1, Samuel Raterink1
1Internal Medicine, Ascension St. John Hospital, Detroit, USA.
Abstract:
Moyamoya disease (MMD) is an infrequent progressive cerebral pathology that primarily affects the branches of the internal carotid artery, resulting in stenosis of the internal carotid artery and subsequent development of multiple collateral vessels. As the disease advances, it manifests through various clinical presentations, including stroke and seizures. Prevalence rates indicate a higher incidence among individuals of Eastern Asian descent, while it is notably less common among African Americans. This case report describes the clinical presentation of a 32-year-old African-American female with a past medical history of sickle cell disease and stroke, who sought medical attention at our institution due to a deterioration in left-sided weakness and left wrist drop. Although the patient had been diagnosed with MMD at an early age, no previous medical records were available. Diagnostic evaluation utilizing brain imaging techniques confirmed the presence of MMD, exhibiting minute collaterals that had replaced the middle cerebral artery.
Insights
This case report details a 32-year-old African-American female with Moyamoya disease (MMD), a rare progressive cerebral condition. The report highlights MMD
Area of Science:
- Neurology
- Vascular Neurology
- Radiology
Background:
- Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder characterized by stenosis of the internal carotid arteries and the development of abnormal collateral vessels.
- It predominantly affects individuals of East Asian descent but can occur in other populations.
- MMD can lead to severe neurological deficits such as stroke and seizures.
Observation:
- This report focuses on a 32-year-old African-American female with a history of sickle cell disease and stroke.
- She presented with worsening left-sided weakness and left wrist drop.
- Despite an early MMD diagnosis, prior medical records were unavailable.
Findings:
- Brain imaging confirmed Moyamoya disease, revealing characteristic minute collateral vessels replacing the middle cerebral artery.
- The patient's presentation of left-sided hemiparesis and wrist drop was consistent with MMD-related ischemic events.
- The case underscores the importance of considering MMD in patients with relevant risk factors and neurological symptoms, even with limited historical data.
Implications:
- This case highlights the importance of recognizing Moyamoya disease in diverse populations, including African Americans.
- It emphasizes the need for comprehensive diagnostic evaluation, including advanced brain imaging, for patients presenting with unexplained neurological deficits.
- Early diagnosis and management of MMD are crucial for preventing progressive neurological damage and improving patient outcomes.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Multiple Allele Traits
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Mitral Stenosis I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy